Home Johnson & Johnson Is A Buy
 

Keywords :   


Johnson & Johnson Is A Buy

2015-09-10 11:06:23| Biotech - Topix.net

Big capital gains not likely here, but investors will get a 3.3% dividend yield with high-single digit dividend growth and a long runway of growth ahead. The broad market correction has made a handful of great companies reasonable once again.

Tags: buy johnson

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Forecast Discussion Number 26
05.07Hurricane Beryl Wind Speed Probabilities Number 26
05.07Hurricane Beryl Forecast Advisory Number 26
05.07Hurricane Beryl Public Advisory Number 26
05.07Tropical Storm Aletta Graphics
05.07Tropical Storm Aletta Wind Speed Probabilities Number 3
05.07Summary for Tropical Storm Aletta (EP1/EP012024)
More »